The HHS will require all new vaccines to undergo placebo-controlled trials, likely slowing down approvals and decreasing access.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Phototherapy with topical antioxidants is the most effective combination for vitiligo, followed by corticosteroids and calcineurin inhibitors.

Prefrontal-cerebellar transcranial pulsed current stimulation significantly improved social functioning and sleep scores over 4 weeks.

Three children have died in the most recent outbreak of measles. This article reviews the symptoms and treatment of measles.

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

Power outages longer than four hours, especially large-scale ones, increased the risk for pediatric carbon monoxide poisoning.

Investment in permanent nurse staffing would decrease hospital costs and improve patient outcomes including mortality.

Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

The majority of patients with advanced melanoma who stop treatment with immune checkpoint inhibitor therapies remain relapse-free.

Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.